PROCEPT BioRobotics (PRCT) Gross Profit (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Gross Profit data on file, last reported at $53.9 million in Q1 2026.

• Quarterly Gross Profit rose 22.16% year-over-year to $53.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $206.0 million (up 31.87% YoY) and the FY2025 annual result came in at $196.2 million, up 43.13% from the prior year.
• Gross Profit rose to $53.9 million in Q1 2026 per PRCT's latest filing, from $46.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $54.0 million in Q3 2025 and bottomed at $7.7 million in Q1 2022.
• The 5-year median for Gross Profit is $25.0 million (2024), against an average of $29.1 million.
• The widest annual swing landed in 2022, when Gross Profit soared 141.3%; it then climbed 6.05% in 2025.
• Tracing PRCT's Gross Profit over 5 years: stood at $10.7 million in 2022, then jumped by 99.09% to $21.3 million in 2023, then surged by 105.47% to $43.7 million in 2024, then climbed by 6.05% to $46.3 million in 2025, then climbed by 16.48% to $53.9 million in 2026.
• Per Business Quant, the three latest PRCT Gross Profit figures stand at $53.9 million (Q1 2026), $46.3 million (Q4 2025), and $54.0 million (Q3 2025).

Peer Comparison